A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
NCT03317223
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
350
Enrollment
INDUSTRY
Sponsor class
Conditions
Helicobacter Pylori Infection
Interventions
DRUG:
CJ-12420/Clarithromycin/Amoxicillin
Sponsor
HK inno.N Corporation